Onyx Pharmaceuticals, Inc.
Idatha yomhlelo osemthethweni
0abalandeli
2013yasungulwa
Mayelana ne-Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
IkomkhuluCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Kusungulwe2013
IsimoKuyasebenza
Amalungelo obunikaziamalungelo obunikazi angu-60
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Ngena ukuze ubone wonke amalungelo obunikazi angu-60
Phequlula lonke iphothifoliyo lamalungelo obunikazi, kanye nezinombolo zokushicilela, izinsuku nemindeni.
Ngena Dala i-akhawunti nge-imeyili yakhoKumahhala
Ngokuqhubeka, uyavumelana ne-Isivumelwano Somsebenzisi, Inqubomgomo Yobumfihlo kanye ne-Inqubomgomo Yamakhukhi ka-Heelky.
Ukubuyekezwa
Azikho izibuyekezo okwamanje. Usebenze ne-Onyx Pharmaceuticals, Inc.? Yiba owokuqala ukwabelana nolwazi lwakho.
Ulwazi lwezomthetho
| Igama elisemthethweni | Onyx Pharmaceuticals, Inc. |
|---|---|
| I-LEI | 549300K47GO90N8J4853Buka ku-GLEIF ↗ |
| Ikheli elibhalisiwe | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Isimo | Kuyasebenza |
Imithombo: GLEIF · kubuyekeziwe Oct. 16, 2026
Ukuxhumana nezixhumanisi
Indawo
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Le inkampani yakho?
Funa leli khasi mahhala ukuze wengeze ilogo yakho, imikhiqizo, izithombe nemisebenzi, futhi uphendule izibuyekezo.
Funa leli khasiJoyina i-Heelky ukuze uxhume, uqashe futhi ukhule
Dala i-akhawunti yamahhala ukuze uthumele umyalezo kubantu, ufake izicelo zemisebenzi futhi ushicilele imisebenzi.
Joyina manje — kumahhala